Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease
- 17 September 2020
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 126 (2) , 135-142
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI 114585)
- National Institutes of Health
- U.S. Department of Veterans Affairs (BX005073)
- U.S. Department of Veterans Affairs (T32 DK007202)
This publication has 100 references indexed in Scilit:
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- Competitive metabolism of L -arginine: arginase as a therapeutic target in asthmaJournal of Biomedical Research, 2011
- A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaClinical & Experimental Allergy, 2011
- Evidence for distinct histologic profile of nasal polyps with and without eosinophiliaThe Laryngoscope, 2011
- Systemically dispersed innate IL-13–expressing cells in type 2 immunityProceedings of the National Academy of Sciences, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptorJournal of Experimental Medicine, 2009
- The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trialJournal of Allergy and Clinical Immunology, 2007
- Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cellsJournal of Allergy and Clinical Immunology, 2006
- Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin‐intolerant asthma after intravenous aspirin challengeClinical & Experimental Allergy, 2004